About COLLIGO BIOMEDICAL, INC
Colligo Biomedical, Inc. develops and manufactures in-vitro diagnostic tools, with a focus on point-of-care devices. Its main goal is to make home-use lateral flow tests quantitative and more accurate by combining standard lateral flow methods with image analysis. This approach aims to improve the detection of small molecule drugs such as fentanyl in a simple and dependable format.
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to COLLIGO BIOMEDICAL, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.